Abstract | METHODS: A prospective, randomized study was conducted with 88 patients undergoing laparoscopic colorectal surgery. The experimental group (S group, n = 44) was given 10 mg of zolpidem tartrate one night before the surgical procedure, while no medication was given to the control group (C group, n = 44). The primary outcome was the intraoperative remifentanil consumption. Sufentanil consumption, average patient-controlled analgesia (PCA) effective press times, the visual analog scale (VAS) scores, and incidences of postoperative nausea and vomiting ( PONV) were recorded at 6 h (T1), 12 h (T2), and 24 h (T3) postoperatively. RESULTS: The intraoperative remifentanil consumption was significantly lower in the S group than that in the C group (p < 0.01). Sufentanil consumption at 6 h and 12 h postoperatively was significantly lower in the S group than that in the C group (p < 0.05); average PCA effective press times and VAS scores, at 6 h and 12 h postoperatively, were significantly lower in the S group than those in the C group (p < 0.01); differences between groups 24 h postoperatively were not significant. No significant between-group difference was noted in the incidence of nausea and vomiting. CONCLUSION:
|
Authors | Zhennan Xiao, Bo Long, Zeji Zhao |
Journal | Pain research & management
(Pain Res Manag)
Vol. 2022
Pg. 3154780
( 2022)
ISSN: 1918-1523 [Electronic] United States |
PMID | 35069955
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Copyright | Copyright © 2022 Zhennan Xiao et al. |
Chemical References |
- Analgesics, Opioid
- Zolpidem
|
Topics |
- Analgesia, Patient-Controlled
(methods)
- Analgesics, Opioid
(therapeutic use)
- Colorectal Surgery
- Double-Blind Method
- Humans
- Laparoscopy
(adverse effects, methods)
- Pain, Postoperative
(drug therapy, epidemiology, etiology)
- Prospective Studies
- Sleep Quality
- Zolpidem
(therapeutic use)
|